$MYGN #Stocks #StockMarket #MyriadGenetics reported Q3 EPS on https://t.co/savSNTKlN1: Weak demand caused increase in losses for the Q3, company's loss per share grew at $-1.55 from $0.09 where Sales fell by -24.284 % to $164.000 MM from $216.600 MM a… https://t.co/oEINTG54Cl